641 related articles for article (PubMed ID: 37210624)
1. NF-κB/NLRP3 inflammasome axis and risk of Parkinson's disease in Type 2 diabetes mellitus: A narrative review and new perspective.
Alrouji M; Al-Kuraishy HM; Al-Gareeb AI; Alexiou A; Papadakis M; Jabir MS; Saad HM; Batiha GE
J Cell Mol Med; 2023 Jul; 27(13):1775-1789. PubMed ID: 37210624
[TBL] [Abstract][Full Text] [Related]
2. Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson's Disease.
Li Y; Xia Y; Yin S; Wan F; Hu J; Kou L; Sun Y; Wu J; Zhou Q; Huang J; Xiong N; Wang T
Front Immunol; 2021; 12():719807. PubMed ID: 34691027
[TBL] [Abstract][Full Text] [Related]
3. The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson's disease via the microglial NLRP3 inflammasome.
Kou L; Chi X; Sun Y; Han C; Wan F; Hu J; Yin S; Wu J; Li Y; Zhou Q; Zou W; Xiong N; Huang J; Xia Y; Wang T
J Neuroinflammation; 2022 Jun; 19(1):133. PubMed ID: 35668454
[TBL] [Abstract][Full Text] [Related]
4. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
[TBL] [Abstract][Full Text] [Related]
5. Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice.
Gordon R; Albornoz EA; Christie DC; Langley MR; Kumar V; Mantovani S; Robertson AAB; Butler MS; Rowe DB; O'Neill LA; Kanthasamy AG; Schroder K; Cooper MA; Woodruff TM
Sci Transl Med; 2018 Oct; 10(465):. PubMed ID: 30381407
[TBL] [Abstract][Full Text] [Related]
6. Baohuoside I suppresses the NLRP3 inflammasome activation via targeting GPER to fight against Parkinson's disease.
Gu Y; Hu ZF; Zheng DW; Yang YQ; Dong XL; Chen WF
Phytomedicine; 2024 Apr; 126():155435. PubMed ID: 38394727
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptors and NLRP3 inflammasome-dependent pathways in Parkinson's disease: mechanisms and therapeutic implications.
Soraci L; Gambuzza ME; Biscetti L; Laganà P; Lo Russo C; Buda A; Barresi G; Corsonello A; Lattanzio F; Lorello G; Filippelli G; Marino S
J Neurol; 2023 Mar; 270(3):1346-1360. PubMed ID: 36460875
[TBL] [Abstract][Full Text] [Related]
8. Wuzi Yanzong Pill relieves MPTP-induced motor dysfunction and neuron loss by inhibiting NLRP3 inflammasome-mediated neuroinflammation.
Pan T; Xiao Q; Fan HJ; Xu L; Qin SC; Yang LX; Jin XM; Xiao BG; Zhang B; Ma CG; Chai Z
Metab Brain Dis; 2023 Oct; 38(7):2211-2222. PubMed ID: 37470879
[TBL] [Abstract][Full Text] [Related]
9. Role of NLRP3 Inflammasome in Parkinson's Disease and Therapeutic Considerations.
Nguyen LTN; Nguyen HD; Kim YJ; Nguyen TT; Lai TT; Lee YK; Ma HI; Kim YE
J Parkinsons Dis; 2022; 12(7):2117-2133. PubMed ID: 35988226
[TBL] [Abstract][Full Text] [Related]
10. Fucoxanthin from microalgae Phaeodactylum tricornutum inhibits pro-inflammatory cytokines by regulating both NF-κB and NLRP3 inflammasome activation.
Lee AH; Shin HY; Park JH; Koo SY; Kim SM; Yang SH
Sci Rep; 2021 Jan; 11(1):543. PubMed ID: 33436909
[TBL] [Abstract][Full Text] [Related]
11. Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease.
Han X; Sun S; Sun Y; Song Q; Zhu J; Song N; Chen M; Sun T; Xia M; Ding J; Lu M; Yao H; Hu G
Autophagy; 2019 Nov; 15(11):1860-1881. PubMed ID: 30966861
[TBL] [Abstract][Full Text] [Related]
12. NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson's Disease.
Han QQ; Le W
Neurosci Bull; 2023 May; 39(5):832-844. PubMed ID: 36757612
[TBL] [Abstract][Full Text] [Related]
13. Neuroinflammation in Parkinson's Disease and its Treatment Opportunities.
Çınar E; Tel BC; Şahin G
Balkan Med J; 2022 Sep; 39(5):318-333. PubMed ID: 36036436
[TBL] [Abstract][Full Text] [Related]
14. Inflammasome inhibition protects dopaminergic neurons from α-synuclein pathology in a model of progressive Parkinson's disease.
Grotemeyer A; Fischer JF; Koprich JB; Brotchie JM; Blum R; Volkmann J; Ip CW
J Neuroinflammation; 2023 Mar; 20(1):79. PubMed ID: 36945016
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson's disease.
Zhou Y; Lu M; Du RH; Qiao C; Jiang CY; Zhang KZ; Ding JH; Hu G
Mol Neurodegener; 2016 Apr; 11():28. PubMed ID: 27084336
[TBL] [Abstract][Full Text] [Related]
16. p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease.
Chen J; Mao K; Yu H; Wen Y; She H; Zhang H; Liu L; Li M; Li W; Zou F
J Neuroinflammation; 2021 Dec; 18(1):295. PubMed ID: 34930303
[TBL] [Abstract][Full Text] [Related]
17. Echinacoside exerts neuroprotection via suppressing microglial α-synuclein/TLR2/NF-κB/NLRP3 axis in parkinsonian models.
Yang XP; Huang JH; Ye FL; Yv QY; Chen S; Li WW; Zhu M
Phytomedicine; 2024 Jan; 123():155230. PubMed ID: 38000105
[TBL] [Abstract][Full Text] [Related]
18. Dl-3-n-Butylphthalide Rescues Dopaminergic Neurons in Parkinson's Disease Models by Inhibiting the NLRP3 Inflammasome and Ameliorating Mitochondrial Impairment.
Que R; Zheng J; Chang Z; Zhang W; Li H; Xie Z; Huang Z; Wang HT; Xu J; Jin D; Yang W; Tan EK; Wang Q
Front Immunol; 2021; 12():794770. PubMed ID: 34925379
[TBL] [Abstract][Full Text] [Related]
19. NLRP3 Inflammasome Inhibition Prevents α-Synuclein Pathology by Relieving Autophagy Dysfunction in Chronic MPTP-Treated NLRP3 Knockout Mice.
Ou Z; Zhou Y; Wang L; Xue L; Zheng J; Chen L; Tong Q
Mol Neurobiol; 2021 Apr; 58(4):1303-1311. PubMed ID: 33169332
[TBL] [Abstract][Full Text] [Related]
20. The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson's disease.
Wang S; Yuan YH; Chen NH; Wang HB
Int Immunopharmacol; 2019 Feb; 67():458-464. PubMed ID: 30594776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
